2026 PREVIOUS DISCUSSANTS
FINANCE CLINIC agenda

Upcoming Finance Clinic

Spring 2027
NYC

*The Finance Clinic has been postponed to Spring 2027 - new date to follow

Who should attend
The Finance Clinic

  • Current C-Suite Life Sciences Executives
  • Advisors to Biotech Companies
  • VPs, Directors, General Counsels, BD Executives
  • Finance Community Members, VCs
  • Board Members, New & Existing

About the Demy-Colton Executive Clinic Series

Upcoming Clinics

  • FINANCE CLINIC: Bringing together biopharma executives and financing experts to explore capital strategies, fundraising decisions, and investor perspectives that drive company growth.
  • DEALMAKING CLINIC: Hear from the most experienced and successful business development executives to discuss strategic objectives, target selection, and negotiation tactics.
  • COMMERCIALIZATION CLINIC: Navigate the transition from R&D to market: explore IP strategy, regulatory pathways, market access, and the operational build needed for successful product launch.
  • BOARD CLINIC: Gain insights into the roles and responsibilities of biotech board members. Equip yourself with actionable steps to position yourself as a sought-after board candidate.
  • LEADERSHIP CLINIC: Optimize leadership strategies to govern with agility, navigate uncertainty, and build a resilient organization for long-term success.

Join the Demy-Colton Executive Clinics—equipping life science leaders with the knowledge and networks to drive success at the highest levels. 

Industry-Specific Agenda covers the following topics:

  • Capital Strategy Across the Company Lifecycle
  • Communicating Complex Science
  • The Anatomy of an Investor's Decision
  • Creative Fundraising and Dealmaking
  • What Makes Companies Investable
  • Partnering & Collaboration
  • Who Develops the Financing Strategy
  • Key Financing Takeaways for Biopharma Companies
2026 PREVIOUS DISCUSSANTS
FINANCE CLINIC agenda

Advisory Committee

  • Dawn Bell, PharmD, CEO & Board Director
  • Jacqueline Kim Blechinger, MBA, Founder Counterpoint B-1
  • Sara Jane Demy, Founder & CEO, Demy-Colton
  • Lori Dernavich, MA, Executive Coach, Lori Dernavich, LLC
  • Mark Kessel, Chairman of the Board, Particles for Humanity
  • Ravi Kiron, PhD, MBA, Managing Director, Biopharma Strategy Advisors
  • Shreefāl Mehta, President, Guidant BioTherapeutics
  • Dennis Purcell, MBA, Founder, Aisling Capital
  • Peter Reikes, MBA, Former Senior Strategy Advisor Advanced Research Projects Agency for Health (ARPA-H)
  • Kate Walsh, Managing Director, Life Science & Healthcare, HSBC Innovation Banking

Sponsor This Event!